EPCAM and neoplasm: In fact, even if EVs constitute only approximately 0.005% of the volume of blood plasma [109], tumor-derived EVs may be isolated from biofluids using tumor-specific or tumor-enriched surface markers (e.g., EpCAM), allowing the analysis of biospecimen enriched in tumor-specific cargo.